Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT

FREE Breaking News Alerts from StreetInsider.com!

E-mail Address

StreetInsider.com Top Tickers, 6/23/2026

1. SPCX
2. NVDA
3. ACN
4. MU
5. USO
6. GOOGL
7. APGE
8. NAVN
9. DFTX
10. IBM

Go back to Biohaven Pharmaceuticals (BHVN) Gains Following Sales Surge for Migraine Drug NURTEC ODT
(NYSE: BHVN) Delayed: 15.50 --0 (-0%)
Previous Close $15.50    52 Week High $ 
Open $15.50    52 Week Low $ 
Day High $15.50    P/E N/A 
Day Low $15.50    EPS $ 
Volume 1,370